PT  - JOURNAL ARTICLE
AU  - J A Robertson
TI  - Extending preimplantation genetic diagnosis: medical and non-medical uses
AID  - 10.1136/jme.29.4.213
DP  - 2003 Aug 01
TA  - Journal of Medical Ethics
PG  - 213--216
VI  - 29
IP  - 4
4099  - http://jme.bmj.com/content/29/4/213.short
4100  - http://jme.bmj.com/content/29/4/213.full
SO  - J Med Ethics2003 Aug 01; 29
AB  - New uses of preimplantation genetic diagnosis (PGD) to screen embryos prior to transfer raise ethical, legal, and policy issues that deserve close attention. Extensions for medical purposes, such as to identify susceptibility genes, late onset disease, and human leukocyte antigen (HLA) matching, are usually ethically acceptable. Whether embryo screening for gender, perfect pitch, or other non-medical characteristics are also acceptable depends upon the parental needs served and the harm posed to embryos, children, and society. Speculations about potential future uses of PGD should not prevent otherwise acceptable current uses of PGD.